Rentschler Biopharma UK Site Approved For AAV Production
After undergoing an inspection by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), Rentschler Biopharma SE's UK facility for advanced therapy medicinal products...
The New Head Office Tax System For The Cross-Border SMEs
Small and medium-sized enterprises (SMEs) often encounter unfair competition while conducting business in Europe. To rectify this issue, the European Commission (EC) has introduced...
Over 50% Of FDA-Approved Drugs To Incorporate AI By 2030
The initial findings from the CPHI Annual Report for 2023, which offers insights from 250 global pharmaceutical companies, indicate that artificial intelligence (AI) is...
Enhancing Gene Therapy Manufacturing, The PAT Project Vision
The Cell and Gene Therapy Catapult is embarking on a two-year project in collaboration with two other organizations, namely contract development and manufacturing organization...
Drug Portfolio Restrictions Imposed By The FTC On Amgen
As per the US Federal Trade Commission (FTC), Amgen is prohibited from using its drug portfolio to unfairly disadvantage its competitors in the industry....
Developing Pharma Skills With Life Sci For Growth Initiative
The UK government dedicates £5.5 million towards establishing a Medicines Manufacturing Skills Centre of Excellence. This center aims to bolster the pool of skilled...
Deciphering The Impact of EU HTA On Emerging Biopharma
What is the Joint European HTA?
Navigating pricing and reimbursement in the European Union (EU) can be a complex task for emerging biopharmaceutical companies (EBPs),...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...